Cargando…
Neurochemical aspects of Alzheimer's disease : risk factors, pathogenesis, biomarkers, and potential treatment strategies /
Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Elsevier Academic Press,
2017.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn988290138 | ||
| 003 | OCoLC | ||
| 005 | 20231120112236.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 170530s2017 enk ob 001 0 eng d | ||
| 010 | |a 2016499981 | ||
| 040 | |a YDX |b eng |e pn |c YDX |d N$T |d IDEBK |d EBLCP |d N$T |d CNCGM |d OCLCF |d YDX |d OCLCO |d OCLCQ |d OPELS |d MERER |d OCLCQ |d UPM |d CASUM |d OCLCO |d OCLCQ |d OCLCA |d D6H |d OCLCO |d DKU |d OCLCO |d OCLCQ |d OCLCO |d U3W |d OCLCO |d AU@ |d WYU |d OCLCO |d OCLCA |d VT2 |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCQ |d S2H |d OCLCO |d LVT |d OCLCO |d OCLCQ |d SFB |d OCLCO | ||
| 016 | 7 | |a 101711864 |2 DNLM | |
| 019 | |a 988557095 |a 1066453481 |a 1229398683 |a 1235837141 | ||
| 020 | |a 9780128099384 |q (electronic bk.) | ||
| 020 | |a 0128099380 |q (electronic bk.) | ||
| 020 | |z 9780128099377 | ||
| 020 | |z 0128099372 | ||
| 035 | |a (OCoLC)988290138 |z (OCoLC)988557095 |z (OCoLC)1066453481 |z (OCoLC)1229398683 |z (OCoLC)1235837141 | ||
| 050 | 4 | |a RC523 | |
| 060 | 4 | |a 2017 G-177 | |
| 060 | 4 | |a WT 155 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.831 |2 23 |
| 100 | 1 | |a Farooqui, Akhlaq A. | |
| 245 | 1 | 0 | |a Neurochemical aspects of Alzheimer's disease : |b risk factors, pathogenesis, biomarkers, and potential treatment strategies / |c Akhlaq A. Farooqui. |
| 260 | |a London : |b Elsevier Academic Press, |c 2017. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed June 8, 2017). | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and therapeutic strategies of AD. The comprehensive and cutting edge information in this monograph may not only help in early detection of AD, but also promote discovery of new drugs to treat this chronic disease. Chapters discuss involvement of neural membrane phospholipids, sphingolipids, and cholesterol-derived lipid mediators, abnormal APP processing, and nucleic acid damage, risk factors, biomarker, and therapeutic strategies of Alzheimer's disease. This book is written for neurologists, neuroscientists, neurochemists, neuropharmacologists, and clinicianswho are interested in molecular mechanisms associated with the pathogenesis of age-related neurological disorders. | ||
| 505 | 8 | |a TAU-INDUCED NEUROTOXICITY IN ALZHEIMER'S DISEASE -- CHALLENGES TO BASIC RESEARCH IN ALZHEIMER'S DISEASE -- CONCLUSION -- References -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- L -- M -- N -- O -- P -- R -- S -- T -- U -- W -- Back Cover. | |
| 650 | 0 | |a Alzheimer's disease |x Pathophysiology. | |
| 650 | 0 | |a Neurochemistry. | |
| 650 | 1 | 2 | |a Alzheimer Disease |x physiopathology |0 (DNLM)D000544Q000503 |
| 650 | 2 | 2 | |a Alzheimer Disease |x therapy |0 (DNLM)D000544Q000628 |
| 650 | 2 | 2 | |a Nervous System |x chemistry |0 (DNLM)D009420Q000737 |
| 650 | 2 | |a Neurochemistry |0 (DNLM)D009448 | |
| 650 | 6 | |a Maladie d'Alzheimer |0 (CaQQLa)201-0114128 |x Physiopathologie. |0 (CaQQLa)201-0379296 | |
| 650 | 6 | |a Neurochimie. |0 (CaQQLa)201-0022100 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Alzheimer's disease |x Pathophysiology |2 fast |0 (OCoLC)fst00806556 | |
| 650 | 7 | |a Neurochemistry |2 fast |0 (OCoLC)fst01036329 | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Internet Resources. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128099377 |z Texto completo |